Anti-adalimumab antibodies are associated with loss of response in juvenile idiopathic arthritis

Abstract Background Secondary drug failure to adalimumab remains a significant challenge in managing Juvenile Idiopathic Arthritis (JIA), with anti-adalimumab antibodies (ADA_ab) implicated as a potential mechanism. This study examines the relationship between ADA_ab formation and loss of response (...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Mikhail Carrim, Muhammad R. A. Shipa, Aicha Bouraoui, Toka AlSulaim, Corinne Fisher, James R. W. Glanville, Maria Leandro, Debajit Sen
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2026-04-01
Σειρά:	Pediatric Rheumatology Online Journal
Θέματα:	Adalimumab Anti-drug antibodies Drug level JIA Loss of response Drug failure
Διαθέσιμο Online:	https://doi.org/10.1186/s12969-026-01213-8
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!